Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 59 entries
Sorted by: Best Match Show Resources per page
The pathophysiology of intestinal lipoprotein production.

Frontiers in physiology

Giammanco A, Cefalù AB, Noto D, Averna MR.
PMID: 25852563
Front Physiol. 2015 Mar 20;6:61. doi: 10.3389/fphys.2015.00061. eCollection 2015.

Intestinal lipoprotein production is a multistep process, essential for the absorption of dietary fats and fat-soluble vitamins. Chylomicron assembly begins in the endoplasmic reticulum with the formation of primordial, phospholipids-rich particles that are then transported to the Golgi for...

Cite
Giammanco A, Cefalù AB, Noto D, et al. The pathophysiology of intestinal lipoprotein production. Front Physiol. 2015;6:61doi: 10.3389/fphys.2015.00061.
Giammanco, A., Cefalù, A. B., Noto, D., & Averna, M. R. (2015). The pathophysiology of intestinal lipoprotein production. Frontiers in physiology, 661. https://doi.org/10.3389/fphys.2015.00061
Giammanco, Antonina, et al. "The pathophysiology of intestinal lipoprotein production." Frontiers in physiology vol. 6 (2015): 61. doi: https://doi.org/10.3389/fphys.2015.00061
Giammanco A, Cefalù AB, Noto D, Averna MR. The pathophysiology of intestinal lipoprotein production. Front Physiol. 2015 Mar 20;6:61. doi: 10.3389/fphys.2015.00061. eCollection 2015. PMID: 25852563; PMCID: PMC4367171.
Copy Download .nbib Format: NLM
Mining the genome for lipid genes.

Biochimica et biophysica acta

Kuivenhoven JA, Hegele RA.
PMID: 24798233
Biochim Biophys Acta. 2014 Oct;1842(10):1993-2009. doi: 10.1016/j.bbadis.2014.04.028. Epub 2014 May 02.

Mining of the genome for lipid genes has since the early 1970s helped to shape our understanding of how triglycerides are packaged (in chylomicrons), repackaged (in very low density lipoproteins; VLDL), and hydrolyzed, and also how remnant and low-density...

Cite
Kuivenhoven JA, Hegele RA. Mining the genome for lipid genes. Biochim Biophys Acta. 2014;1842(10):1993-2009doi: 10.1016/j.bbadis.2014.04.028.
Kuivenhoven, J. A., & Hegele, R. A. (2014). Mining the genome for lipid genes. Biochimica et biophysica acta, 1842(10), 1993-2009. https://doi.org/10.1016/j.bbadis.2014.04.028
Kuivenhoven, Jan Albert, and Hegele, Robert A. "Mining the genome for lipid genes." Biochimica et biophysica acta vol. 1842,10 (2014): 1993-2009. doi: https://doi.org/10.1016/j.bbadis.2014.04.028
Kuivenhoven JA, Hegele RA. Mining the genome for lipid genes. Biochim Biophys Acta. 2014 Oct;1842(10):1993-2009. doi: 10.1016/j.bbadis.2014.04.028. Epub 2014 May 02. PMID: 24798233.
Copy Download .nbib Format: NLM
DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. I. CORRELATION WITH PLASMA ANTIOXIDANT LEVELS AND COMPOSITION OF LIPOPROTEINS.

Pharmacological research

Perugini C, Bagnati M, Cau C, Bordone R, Zoppis E, Paffoni P, Re R, Albano E, Bellomo G.
PMID: 10712827
Pharmacol Res. 2000 Jan;41(1):53-63. doi: 10.1006/phrs.1999.0552.

The concentration of five lipid-soluble antioxidants (gamma- and alpha-tocopherol, lycopene, beta-carotene and ubiquinol-10) was measured in plasma and very low-density, low-density and high-density lipoproteins (VLDL, LDL and HDL) isolated from young healthy normo- cholesterolemic subjects. Alpha-tocopherol was the exclusive...

Cite
Perugini C, Bagnati M, Cau C, et al. DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. I. CORRELATION WITH PLASMA ANTIOXIDANT LEVELS AND COMPOSITION OF LIPOPROTEINS. Pharmacol Res. 2000;41(1):53-63doi: 10.1006/phrs.1999.0552.
Perugini, C., Bagnati, M., Cau, C., Bordone, R., Zoppis, E., Paffoni, P., Re, R., Albano, E., & Bellomo, G. (2000). DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. I. CORRELATION WITH PLASMA ANTIOXIDANT LEVELS AND COMPOSITION OF LIPOPROTEINS. Pharmacological research, 41(1), 53-63. https://doi.org/10.1006/phrs.1999.0552
Perugini, et al. "DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. I. CORRELATION WITH PLASMA ANTIOXIDANT LEVELS AND COMPOSITION OF LIPOPROTEINS." Pharmacological research vol. 41,1 (2000): 53-63. doi: https://doi.org/10.1006/phrs.1999.0552
Perugini C, Bagnati M, Cau C, Bordone R, Zoppis E, Paffoni P, Re R, Albano E, Bellomo G. DISTRIBUTION OF LIPID-SOLUBLE ANTIOXIDANTS IN LIPOPROTEINS FROM HEALTHY SUBJECTS. I. CORRELATION WITH PLASMA ANTIOXIDANT LEVELS AND COMPOSITION OF LIPOPROTEINS. Pharmacol Res. 2000 Jan;41(1):53-63. doi: 10.1006/phrs.1999.0552. PMID: 10712827.
Copy Download .nbib Format: NLM
Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Nutrition & metabolism

Sundaram M, Yao Z.
PMID: 20423497
Nutr Metab (Lond). 2010 Apr 27;7:35. doi: 10.1186/1743-7075-7-35.

Excess lipid induced metabolic disorders are one of the major existing challenges for the society. Among many different causes of lipid disorders, overproduction and compromised catabolism of triacylglycerol-rich very low density lipoproteins (VLDL) have become increasingly prevalent leading to...

Cite
Sundaram M, Yao Z. Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion. Nutr Metab (Lond). 2010;7:35doi: 10.1186/1743-7075-7-35.
Sundaram, M., & Yao, Z. (2010). Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion. Nutrition & metabolism, 735. https://doi.org/10.1186/1743-7075-7-35
Sundaram, Meenakshi, and Yao, Zemin. "Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion." Nutrition & metabolism vol. 7 (2010): 35. doi: https://doi.org/10.1186/1743-7075-7-35
Sundaram M, Yao Z. Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion. Nutr Metab (Lond). 2010 Apr 27;7:35. doi: 10.1186/1743-7075-7-35. PMID: 20423497; PMCID: PMC2873297.
Copy Download .nbib Format: NLM
[Membrane fluidity and obesity: the correct food approach].

Minerva gastroenterologica e dietologica

Cestaro B, Cazzola R, Rondanelli M, Ferrari E.
PMID: 16493376
Minerva Gastroenterol Dietol. 2001 Dec;47(4):181-5.

Modifications in dietary fat profile have shown to affect body weight gain and adiposity. This may occur through the changes of cell membrane fluidity, in particular of the peripheral muscle tissue. The decreased availability of diet polyunsaturated fatty acids...

Cite
Cestaro B, Cazzola R, Rondanelli M, et al. Fluidità di membrana e obesità (il corretto approccio alimentare). [Membrane fluidity and obesity: the correct food approach]. Minerva Gastroenterol Dietol. 2001;47(4):181-5
Cestaro, B., Cazzola, R., Rondanelli, M., & Ferrari, E. (2001). Fluidità di membrana e obesità (il corretto approccio alimentare). [Membrane fluidity and obesity: the correct food approach]. Minerva gastroenterologica e dietologica, 47(4), 181-5.
Cestaro, B, et al. "Fluidità di membrana e obesità (il corretto approccio alimentare)." [Membrane fluidity and obesity: the correct food approach]. Minerva gastroenterologica e dietologica vol. 47,4 (2001): 181-5.
Cestaro B, Cazzola R, Rondanelli M, Ferrari E. Fluidità di membrana e obesità (il corretto approccio alimentare). [Membrane fluidity and obesity: the correct food approach]. Minerva Gastroenterol Dietol. 2001 Dec;47(4):181-5. Italian. PMID: 16493376.
Copy Download .nbib Format: NLM
Effects of a (n-3) polyunsaturated fatty acid-deficient diet on profiles of serum vitellogenin and lipoprotein in vitellogenic trout (Salmo gairdneri).

Lipids

Frémont L, Léger C, Petridou B, Gozzelino MT.
PMID: 21344281
Lipids. 1984 Jul;19(7):522-8. doi: 10.1007/BF02534485.

During the 6 months of vitellogenesis, 3-year-old female trout (Salmo gairdneri) were fed either an enriched (E) or an (n-3) polyunsaturated fatty acid (PUFA)-deficient (D) diet; serum vitellogenin (VG) and lipoproteins (d

Cite
Frémont L, Léger C, Petridou B, et al. Effects of a (n-3) polyunsaturated fatty acid-deficient diet on profiles of serum vitellogenin and lipoprotein in vitellogenic trout (Salmo gairdneri). Lipids. 1984;19(7):522-8doi: 10.1007/BF02534485.
Frémont, L., Léger, C., Petridou, B., & Gozzelino, M. T. (1984). Effects of a (n-3) polyunsaturated fatty acid-deficient diet on profiles of serum vitellogenin and lipoprotein in vitellogenic trout (Salmo gairdneri). Lipids, 19(7), 522-8. https://doi.org/10.1007/BF02534485
Frémont, L, et al. "Effects of a (n-3) polyunsaturated fatty acid-deficient diet on profiles of serum vitellogenin and lipoprotein in vitellogenic trout (Salmo gairdneri)." Lipids vol. 19,7 (1984): 522-8. doi: https://doi.org/10.1007/BF02534485
Frémont L, Léger C, Petridou B, Gozzelino MT. Effects of a (n-3) polyunsaturated fatty acid-deficient diet on profiles of serum vitellogenin and lipoprotein in vitellogenic trout (Salmo gairdneri). Lipids. 1984 Jul;19(7):522-8. doi: 10.1007/BF02534485. PMID: 21344281.
Copy Download .nbib Format: NLM
Cardiovascular risk factors and cognitive performance in aging.

Dementia & neuropsychologia

Takeda JRT, Matos TM, de Souza-Talarico JN.
PMID: 29354226
Dement Neuropsychol. 2017 Oct-Dec;11(4):442-448. doi: 10.1590/1980-57642016dn11-040015.

BACKGROUND: Atherosclerosis in cerebral blood vessels, especially those which compose the Circle of Willis, can lead to reduced supply of oxygen and nutrients to different cortical structures, affecting cognitive function.OBJECTIVE: To analyze whether cardiovascular risk factors negatively influence cognitive...

Cite
Takeda JRT, Matos TM, de Souza-Talarico JN. Cardiovascular risk factors and cognitive performance in aging. Dement Neuropsychol. 2017;11(4):442-448doi: 10.1590/1980-57642016dn11-040015.
Takeda, J. R. T., Matos, T. M., & de Souza-Talarico, J. N. (2017). Cardiovascular risk factors and cognitive performance in aging. Dementia & neuropsychologia, 11(4), 442-448. https://doi.org/10.1590/1980-57642016dn11-040015
Takeda, Juliana Rumy Tsuchihashi, et al. "Cardiovascular risk factors and cognitive performance in aging." Dementia & neuropsychologia vol. 11,4 (2017): 442-448. doi: https://doi.org/10.1590/1980-57642016dn11-040015
Takeda JRT, Matos TM, de Souza-Talarico JN. Cardiovascular risk factors and cognitive performance in aging. Dement Neuropsychol. 2017 Oct-Dec;11(4):442-448. doi: 10.1590/1980-57642016dn11-040015. PMID: 29354226; PMCID: PMC5770004.
Copy Download .nbib Format: NLM
Effects of Supplementation and Training on Ameliorating Lipid Profiles and Protection against Coronary Artery Disease; an Experimental Study.

Archives of academic emergency medicine

Vafaee R, Soori H, Hedayati M, Hatamabadi HR.
PMID: 31432026
Arch Acad Emerg Med. 2019 Feb 12;7(1):e16. eCollection 2019.

INTRODUCTION: The use of antioxidants may reduce the harmful effects of radicals during exercise and extreme sports. The Current study aimed to investigate the effect of this supplement on the lipid profiles in exercise-induced muscle injury.METHODS: In this experimental...

Cite
Vafaee R, Soori H, Hedayati M, et al. Effects of Supplementation and Training on Ameliorating Lipid Profiles and Protection against Coronary Artery Disease; an Experimental Study. Arch Acad Emerg Med. 2019;7(1):e16
Vafaee, R., Soori, H., Hedayati, M., & Hatamabadi, H. R. (2019). Effects of Supplementation and Training on Ameliorating Lipid Profiles and Protection against Coronary Artery Disease; an Experimental Study. Archives of academic emergency medicine, 7(1), e16.
Vafaee, Reza, et al. "Effects of Supplementation and Training on Ameliorating Lipid Profiles and Protection against Coronary Artery Disease; an Experimental Study." Archives of academic emergency medicine vol. 7,1 (2019): e16.
Vafaee R, Soori H, Hedayati M, Hatamabadi HR. Effects of Supplementation and Training on Ameliorating Lipid Profiles and Protection against Coronary Artery Disease; an Experimental Study. Arch Acad Emerg Med. 2019 Feb 12;7(1):e16. eCollection 2019. PMID: 31432026; PMCID: PMC6637803.
Copy Download .nbib Format: NLM
[Incidence of thyroid and cardiovascular diseases in menopausal females].

Problemy endokrinologii

Izmozherova NV, Popov AA, Stryukova OY, Andreyev AN, Tagiltseva NV.
PMID: 31627630
Probl Endokrinol (Mosk). 2007 Feb 15;53(1):36-40. doi: 10.14341/probl200753136-40.

The purpose of the study was to estimate the incidence of thyroid dysfunction and cardiovascular diseases in perimenopausal females. The cross-sectional study covered 554 females (mean age 52.6±6.1 years). The levels of thyroid-stimulating hormone (TSH), total cholesterol (TC), high-density...

Cite
Izmozherova NV, Popov AA, Stryukova OY, et al. [Incidence of thyroid and cardiovascular diseases in menopausal females]. Probl Endokrinol (Mosk). 2007;53(1):36-40doi: 10.14341/probl200753136-40.
Izmozherova, N. V., Popov, A. A., Stryukova, O. Y., Andreyev, A. N., & Tagiltseva, N. V. (2007). [Incidence of thyroid and cardiovascular diseases in menopausal females]. Problemy endokrinologii, 53(1), 36-40. https://doi.org/10.14341/probl200753136-40
Izmozherova, N V, et al. "[Incidence of thyroid and cardiovascular diseases in menopausal females]." Problemy endokrinologii vol. 53,1 (2007): 36-40. doi: https://doi.org/10.14341/probl200753136-40
Izmozherova NV, Popov AA, Stryukova OY, Andreyev AN, Tagiltseva NV. [Incidence of thyroid and cardiovascular diseases in menopausal females]. Probl Endokrinol (Mosk). 2007 Feb 15;53(1):36-40. doi: 10.14341/probl200753136-40. Russian. PMID: 31627630.
Copy Download .nbib Format: NLM
[New possibilities of genotypic in the prediction of the likelihood of autoimmune diseases].

Problemy endokrinologii

Dedov II, Khaitov RM, Alekseyev LP, Boldyreva MN.
PMID: 31627631
Probl Endokrinol (Mosk). 2007 Feb 15;53(1):40-42. doi: 10.14341/probl200753140-42.

The purpose of the study was to estimate the incidence of thyroid dysfunction and cardiovascular diseases in perimenopausal females. The cross-sectional study covered 554 females (mean age 52.6±6.1 years). The levels of thyroid-stimulating hormone (TSH), total cholesterol (TC), high-density...

Cite
Dedov II, Khaitov RM, Alekseyev LP, et al. [New possibilities of genotypic in the prediction of the likelihood of autoimmune diseases]. Probl Endokrinol (Mosk). 2007;53(1):40-42doi: 10.14341/probl200753140-42.
Dedov, I. I., Khaitov, R. M., Alekseyev, L. P., & Boldyreva, M. N. (2007). [New possibilities of genotypic in the prediction of the likelihood of autoimmune diseases]. Problemy endokrinologii, 53(1), 40-42. https://doi.org/10.14341/probl200753140-42
Dedov, I I, et al. "[New possibilities of genotypic in the prediction of the likelihood of autoimmune diseases]." Problemy endokrinologii vol. 53,1 (2007): 40-42. doi: https://doi.org/10.14341/probl200753140-42
Dedov II, Khaitov RM, Alekseyev LP, Boldyreva MN. [New possibilities of genotypic in the prediction of the likelihood of autoimmune diseases]. Probl Endokrinol (Mosk). 2007 Feb 15;53(1):40-42. doi: 10.14341/probl200753140-42. Russian. PMID: 31627631.
Copy Download .nbib Format: NLM
The Importance of Lipoprotein Lipase Regulation in Atherosclerosis.

Biomedicines

Kumari A, Kristensen KK, Ploug M, Winther AL.
PMID: 34356847
Biomedicines. 2021 Jul 06;9(7). doi: 10.3390/biomedicines9070782.

Lipoprotein lipase (LPL) plays a major role in the lipid homeostasis mainly by mediating the intravascular lipolysis of triglyceride rich lipoproteins. Impaired LPL activity leads to the accumulation of chylomicrons and very low-density lipoproteins (VLDL) in plasma, resulting in...

Cite
Kumari A, Kristensen KK, Ploug M, et al. The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines. 2021;9(7)doi: 10.3390/biomedicines9070782.
Kumari, A., Kristensen, K. K., Ploug, M., & Winther, A. L. (2021). The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines, 9(7), . https://doi.org/10.3390/biomedicines9070782
Kumari, Anni, et al. "The Importance of Lipoprotein Lipase Regulation in Atherosclerosis." Biomedicines vol. 9,7 (2021). doi: https://doi.org/10.3390/biomedicines9070782
Kumari A, Kristensen KK, Ploug M, Winther AL. The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines. 2021 Jul 06;9(7). doi: 10.3390/biomedicines9070782. PMID: 34356847; PMCID: PMC8301479.
Copy Download .nbib Format: NLM
New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis.

Pharmacology & therapeutics

Gautier T, Deckert V, Nguyen M, Desrumaux C, Masson D, Lagrost L.
PMID: 34974028
Pharmacol Ther. 2021 Dec 30;108105. doi: 10.1016/j.pharmthera.2021.108105. Epub 2021 Dec 30.

Phospholipid Transfer Protein (PLTP) transfers amphiphilic lipids between circulating lipoproteins and between lipoproteins, cells and tissues. Indeed, PLTP is a major determinant of the plasma levels, turnover and functionality of the main lipoprotein classes: very low-density lipoproteins (VLDL), low-density...

Cite
Gautier T, Deckert V, Nguyen M, et al. New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis. Pharmacol Ther. 2021;108105doi: 10.1016/j.pharmthera.2021.108105.
Gautier, T., Deckert, V., Nguyen, M., Desrumaux, C., Masson, D., & Lagrost, L. (2021). New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis. Pharmacology & therapeutics, 108105. https://doi.org/10.1016/j.pharmthera.2021.108105
Gautier, Thomas, et al. "New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis." Pharmacology & therapeutics vol. (2021): 108105. doi: https://doi.org/10.1016/j.pharmthera.2021.108105
Gautier T, Deckert V, Nguyen M, Desrumaux C, Masson D, Lagrost L. New therapeutic horizons for plasma phospholipid transfer protein (PLTP): Targeting endotoxemia, infection and sepsis. Pharmacol Ther. 2021 Dec 30;108105. doi: 10.1016/j.pharmthera.2021.108105. Epub 2021 Dec 30. PMID: 34974028.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 59 entries